Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.
Periodic limb movements during REM sleep in multiple sclerosis: a previously undescribed entity.
Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions.
Novel computer vision algorithm for the reliable analysis of organelle morphology in whole cell 3D images - A pilot study for the quantitative evaluation of mitochondrial fragmentation in amyotrophic lateral sclerosis.
Cost-Effectiveness of Dimethyl Fumarate Treatment for Relapsing-Remitting Multiple Sclerosis From A Danish Perspective.
Caffeine treatment aggravates secondary degeneration after spinal cord injury.
Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception.
Clinical outcome measures in multiple sclerosis.
Regulatory genomic regions active in immune cell types explain a large proportion of the genetic risk of multiple sclerosis.
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants.
HHV-6-positivity in diseases with demyelination.
Cost minimisation analysis of fingolimod vs natalizumab as a second line of treatment for relapsing-remitting multiple sclerosis.
Prospective study on retinal nerve fibre layer thickness changes in isolated unilateral retrobulbar optic neuritis.
CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
Progressive multifocal leukoencephalopathy in an immunocompetent patient.
Current and Emerging Therapies for Multiple Sclerosis.
Elevated In Vivo Levels of a Single Transcription Factor Directly Convert Satellite Glia into Oligodendrocyte-like Cells.
Clinical applications at ultrahigh field (7 T). Where does it make the difference?
Oral contraceptives combined with interferon β in multiple sclerosis.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Interpretation of magnetization transfer from inhomogeneously broadened lines (ihMT) in tissues as a dipolar order effect within motion restricted molecules.
Exploring strategies used following a group-based fatigue management programme for people with multiple sclerosis (FACETS) via the Fatigue Management Strategies Questionnaire (FMSQ).

Pages